chitosan has been researched along with Peritonitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Cao, A; Cao, M; Wang, Q; Xing, J; Zhang, J; Zhu, W | 1 |
| Jain, V; Mishra, PR; Pal, R; Shukla, P | 1 |
2 other study(ies) available for chitosan and Peritonitis
| Article | Year |
|---|---|
Pickering emulsion stabilized by parasin I and chitosan nanoparticles enhances protection against intestinal microbiota homeostasis by reducing inflammation in peritonitis mice.
Topics: Animals; Chitosan; Emulsions; Gastrointestinal Microbiome; Inflammation; Mice; Mice, Inbred NOD; Nanoparticles; NLR Family, Pyrin Domain-Containing 3 Protein; Particle Size; Peritonitis | 2023 |
Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.
Topics: Animals; Anti-Bacterial Agents; Cations; Chitosan; Ciprofloxacin; Deoxycholic Acid; Drug Carriers; Emulsions; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Microbial Sensitivity Tests; Nanostructures; Particle Size; Peritonitis; Rats, Wistar; Sepsis; Technology, Pharmaceutical | 2014 |